Effects of Pituitary Adenylate Cyclase Activating Polypeptide and Its Fragments on Retinal Degeneration Induced by Neonatal Monosodium Glutamate Treatment
- 27 April 2009
- journal article
- Published by Wiley in Annals of the New York Academy of Sciences
- Vol. 1163 (1) , 348-352
Abstract
Pituitary adenylate cyclase activating polypeptide (PACAP) is a member of the growing family of neurotrophic and neuroprotective factors playing important roles during neuronal development and protection against different types of injuries, such as Parkinson's disease, excitotoxicity, and ischemia. As shown with other neuronal tissues, we provide evidence that PACAP is protective in the retina against toxic injury induced by monosodium glutamate (MSG)in vivo. The need for characterization of its fragments and analogues has recently been emphasized. The aim of the present study was to compare the effects of the physiologically occurring fragments PACAP1–38 and 1–27 and the widely used antagonists (PACAP6–38 and 6–27) in retinal degeneration induced by MSG in neonatal pups. Histological analysis showed that MSG treatment caused the degeneration of the entire inner plexiform layer and the inner nuclear and ganglion cell layers seemed fused. The total thickness of the retina was significantly reduced. Similar and substantial protective effects could be observed after three treatments with PACAP1–38 and 1–27, while MSG toxicity was further aggravated by the PACAP antagonists PACAP6–38 and 6–27. Glutamate‐induced toxicity is known to play a role in several retinal pathologies. Our results provide further evidence for the effectiveness of the endogenously present PACAP forms in counteracting retinotoxicity and call for further studies leading to the discovery of potent analogues that could be used in human ophthalmic diseases.Keywords
This publication has 19 references indexed in Scilit:
- Suppression of Ganglion Cell Death by PACAP Following Optic Nerve Transection in the RatJournal of Molecular Neuroscience, 2008
- Agonistic Behavior of PACAP6-38 on Sensory Nerve Terminals and Cytotrophoblast CellsJournal of Molecular Neuroscience, 2008
- Novel stable PACAP analogs with potent activity towards the PAC1 receptorPeptides, 2008
- Biological and Structural Analysis of Truncated Analogs of PACAP27Journal of Molecular Neuroscience, 2008
- Effects of pituitary adenylate cyclase activating polypeptide (PACAP) on the PKA-bad-14-3-3 signaling pathway in glutamate-induced retinal injury in neonatal ratsNeurotoxicity Research, 2007
- Pituitary adenylate cyclase activating polypeptide is protective in bilateral carotid occlusion-induced retinal lesion in ratsGeneral and Comparative Endocrinology, 2006
- The neuroprotective effects of PACAP in monosodium glutamate-induced retinal lesion involve inhibition of proapoptotic signaling pathwaysRegulatory Peptides, 2006
- Neuroprotective Effect of PACAP against Kainic Acid‐Induced Neurotoxicity in Rat RetinaAnnals of the New York Academy of Sciences, 2006
- PACAP Stimulates the Release of Interleukin‐6 in Cultured Rat Müller CellsAnnals of the New York Academy of Sciences, 2006
- Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by monosodium-glutamateNeuroscience Letters, 2004